English Archives - Page 11 of 23

15 May, 2024

Sidra Medicine Hosts Inaugural Conference on Primary Immune Dysregulation Disorders

15 May 2024, Doha, Qatar – Sidra Medicine, in collaboration with the MENAT-NIAID initiative, proudly hosted the Recent Advances in Primary Immunodysregulation Disorders (RAPID) conference on the 9th and 10th of

14 May, 2024

Sidra Medicine to Establish Qatar’s First-Ever Pediatric Hematopoietic Stem Cell Transplant Program

14 May 2024, Doha, Qatar – Sidra Medicine, a QF entity, is proud to announce the upcoming establishment of the first-ever pediatric hematopoietic stem cell transplant (HSCT) program in Qatar, in partnership with one of the world’s leading pediatric hospitals, Children’s Hospital of Philadelphia (CHOP).

22 April, 2024

Sidra Medicine Leads Largest Research on Rare Genetic Disease Risk in the Middle East

A study by Sidra Medicine, a member of Qatar Foundation, on rare genetic diseases in a wide-ranging and diverse Middle Eastern cohort from Qatar, has been published in the prestigious Genome Medicine journal1.

1 April, 2024

First Arab Middle Eastern Genetics Research in Autism Going Global

On World Autism Awareness Day, Sidra Medicine, a member of Qatar Foundation, celebrates the profound impact of its long-standing initiative, the BARAKA-Qatar study1 (Building a Resource for the Advancement of Knowledge of Autism in Qatar).

12 March, 2024

Sidra Medicine Appoints Wouter Van den Brande as New Chief Operating Officer

12 March 2024, Doha, Qatar – Sidra Medicine has appointed Mr. Wouter Van den Brande as its new Chief Operating Officer (COO). As COO of Sidra Medicine, Wouter's responsibilities will include overseeing and expanding the

28 February, 2024

Sidra Medicine Empowers Rare Disease Research

QF Entity opens accessibility to state-of-the-art research services 28 February 2024, Doha, Qatar – In support of Rare Disease Day, Sidra Medicine today announced the accessibility of its unique and state-of-the-art research technologies

26 February, 2024

Sidra Medicine and Msheireb Museums Launch Science Café Series

QF Entities to bring science to the community 26 February 2024, Doha, Qatar – Sidra Medicine and Msheireb Museums, members of Qatar Foundation, are launching their first Science Café series. The Science Café concept

6 February, 2024

Sidra Medicine Expands ENT Services

QF Entity performs first pediatric vocal cord injection medialization procedure 06 February 2024, Doha, Qatar –Sidra Medicine, a member of Qatar Foundation, has expanded its pediatric Otolaryngology (ear, nose and throat)

28 January, 2024

Sidra Medicine Pioneers New Pediatric Treatment Protocol for Infant with Congenital Hyperinsulinism

In a world first, Sidra Medicine, a member of Qatar Foundation, has pioneered a new treatment protocol for a young infant with congenital hyperinsulinism. The findings have been published in the prestigious New England Journal of Medicine.

Amel Khalifa

Sidra Medicine Hosts Inaugural Conference on Primary Immune Dysregulation Disorders

Sidra Medicine to Establish Qatar’s First-Ever Pediatric Hematopoietic Stem Cell Transplant Program

Sidra Medicine Leads Largest Research on Rare Genetic Disease Risk in the Middle East

First Arab Middle Eastern Genetics Research in Autism Going Global

Sidra Medicine Appoints Wouter Van den Brande as New Chief Operating Officer

Sidra Medicine Empowers Rare Disease Research

Sidra Medicine and Msheireb Museums Launch Science Café Series

Sidra Medicine Expands ENT Services

Sidra Medicine Pioneers New Pediatric Treatment Protocol for Infant with Congenital Hyperinsulinism

Our Insurance Partners